Drug Type Small molecule drug |
Synonyms- |
Target |
Action negative allosteric modulator |
Mechanism GluN2A negative allosteric modulator(glutamate ionotropic receptor NMDA type subunit 2A negative allosteric modulator) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H17ClFN3O4S |
InChIKeyFYIBXBFDXNPBSF-UHFFFAOYSA-N |
CAS Registry852918-02-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Brain Diseases | Preclinical | United States | 09 May 2025 |





